137 related articles for article (PubMed ID: 3542345)
1. Short-course drug therapy for tuberculosis.
Stratton MA; Reed MT
Clin Pharm; 1986 Dec; 5(12):977-87. PubMed ID: 3542345
[TBL] [Abstract][Full Text] [Related]
2. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
[TBL] [Abstract][Full Text] [Related]
3. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
4. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
Aquinas M
Bull Int Union Tuberc; 1978 Dec; 53(4):253. PubMed ID: 387136
[No Abstract] [Full Text] [Related]
5. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
[TBL] [Abstract][Full Text] [Related]
7. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
Wada M
Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
9. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
Brändli O; Dreher D; Morger D
Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
[TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1987 Dec; 136(6):1339-42. PubMed ID: 2891333
[TBL] [Abstract][Full Text] [Related]
11. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
12. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
Kameda K; Kawabata S; Masuda N
Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
[TBL] [Abstract][Full Text] [Related]
13. Current tuberculosis treatment regimens. Choosing the right one for your patient.
Pérez-Stable EJ; Hopewell PC
Clin Chest Med; 1989 Sep; 10(3):323-39. PubMed ID: 2673644
[TBL] [Abstract][Full Text] [Related]
14. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
[TBL] [Abstract][Full Text] [Related]
15. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
16. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
Yan S; Ye H; Lin S
Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Teo SK
Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
[TBL] [Abstract][Full Text] [Related]
18. [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
Mazouni L; Tazir M; Boulahbal F; Chaulet P
Rev Mal Respir; 1985; 2(4):209-14. PubMed ID: 3937189
[TBL] [Abstract][Full Text] [Related]
19. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
20. Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
Balasubramanian R; Nagarajan M; Balambal R; Tripathy SP; Sundararaman R; Venkatesan P; Paramasivam CN; Rajasambandam P; Rangabashyam N; Prabhakar R
Int J Tuberc Lung Dis; 1997 Feb; 1(1):44-51. PubMed ID: 9441058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]